Jennifer Woyach
Clinical trials sponsored by Jennifer Woyach, explained in plain language.
-
Early drug attack on silent blood cancer
Disease control OngoingThis study is testing whether starting a cancer drug called ibrutinib early, before symptoms appear, can better control high-risk forms of chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL). It involves 42 patients who have these cancers with specific high-ri…
Phase: PHASE2 • Sponsor: Jennifer Woyach • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
Early trial tests Two-Drug attack on blood cancer
Disease control OngoingThis early-stage study is testing the safety and effectiveness of combining two drugs, daratumumab and ibrutinib, for people with chronic lymphocytic leukemia (CLL) who have symptoms but have not yet received any treatment. The goal is to see if using these drugs together works b…
Phase: PHASE1 • Sponsor: Jennifer Woyach • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC